Abstract CT136: Phase I Study with Rapamycin Combined with Irinotecan, the SFCE RAPIRI I Trial, a New Way to Target Tumor Hypoxia in Pediatric Refractory Cancers
Cancer research(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Cancer research(2020)